CUPID: Transforming Cancer of Unknown Primary with Intelligent Diagnostics

Not Applicable

• Conditions: Cancer; Cancer - Any cancer

• Registration Number: ACTRN12623001221640
• Lead Sponsor: Flinders University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-11-28
• Last Update Posted: 4 December 2023

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

Eligible participants must fulfill all the following criteria:
1.Age 18 years or more
2.Suspected or confirmed CUP diagnosis
3.Willing to provide informed consent
4.Able to understand English or understand study involvement through interpreter services
5.No prior systemic therapy for the treatment of CUP
•Patients who have received prior surgery and/or radiotherapy (including radioembolization of tumour) are eligible upon evidence of cancer recurrence or progression.

Exclusion Criteria

Patients who meet any of the following criteria will be excluded from study entry:
1.Metastatic disease from a known primary site
2.Patients with histology and immunohistology profiles (per 2015 ESMO guidelines) that are compatible with extragonadal germ-cell tumours, neuroendocrine tumours, sarcoma, melanoma, mesothelioma, haematological malignancies (this list is not limitative)

Study & Design

• Study Type: Interventional
• Study Design: Not specified